do glp 1 cause osteoporosis drugs have been linked to up to 30% bone loss in studies. It's imperative you protect your muscle and bone from damage if you decide to use these injections. ***Medical While the study doesn't prove

What to Look for in a Copper Peptide Serum Not all peptide serums are created equal

Community-reported protocols typically pair melanotan-1 with brief UV exposure to accelerate and deepen the melanogenic response

In this study, participants taking orforglipron experienced an average A1C reduction of 2.1% and an average weight loss of 10.1 kilograms at 26 weeks, which was significantly greater than those in the placebo and dulaglutide groups

Calcium, the main building block of bone, can only be properly absorbed when vitamin D is present

Expert Consensus: American College of Physicians: GLP-1 receptor agonists should be considered for patients with obesity who have not achieved weight loss goals with lifestyle modifications. Endocrine Society: Semaglutide and tirzepatide represent significant advances in obesity pharmacotherapy and should be considered first-line options. Obesity Medicine Association: The dramatic efficacy of GLP-1 and dual agonist medications has fundamentally changed the treatment landscape for obesity. Real-World Effectiveness: Studies of patients using these medications outside clinical trials show: GLP-1s: Similar to clinical trial results (confirming real-world effectiveness) Older medications: Often less effective in real-world than trials (adherence issues) Patient satisfaction: Highest with GLP-1s Bottom Line: Which Works Best